GlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q2 2022 Results - Earnings Call Transcript

GlycoMimetics, Inc. (NASDAQ:NASDAQ:GLYC) Q2 2022 Earnings Conference Call August 03, 2022 08:30 AM ET Company Participants Christian Dinneen-Long - Company Counsel Harout Semerjian - Chief...

Related Keywords

New York ,United States ,Australia ,Canada ,Christian Dinneen ,Bruce Johnson ,Harout Semerjian ,Steve Bersey ,Brian Hahn ,Red White ,Company Participants ,National Cancer Institute ,Glycomimetics Inc ,Company Counsel ,Nasdaq ,National Comprehensive Cancer Network ,Conference Call August ,Christian Dinneen Long ,Investor Relations ,Chief Executive Officer ,Chief Financial Officer ,Chief Commercial ,Chief Commercial Officer ,Annual Conference ,Boris Peaker ,Roger Song ,Global Investment Conference ,